Back to User profile » Dr Joanna M Rhodes
Paper published by Dr Joanna M Rhodes:
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia
Rhodes JM, Mato AR
Drug Design, Development and Therapy 2021, 15:919-926
Published Date: 2 March 2021